Summary:
A Randomized, Placebo-controlled Trial to Evaluate the Longer-term (ie, Maintenance) Efficacy of Oral Aripiprazole in the Treatment of Pediatric Subjects with Tourette’s Disorder.
Qualified Participants Must:
• The subject is a male or female child or adolescent, 6 to 17 years of age (inclusive) at the time of signing the informed consent/assent
•
The subject, a caregiver, and the investigator must all agree that the presenting tic symptoms cause impairment in the subject's normal routines, which include academic achievement, occupational functioning, social activities, and/or relationships.
Qualified Participants May Receive:
Compensation for time and travel; $50.00 per completed visit